MHES Statement on Use of Paracetamol During Pregnancy

The Ministry of Health, Environment and Sustainability would like to remind the public that the use of paracetamol during pregnancy remains safe.

“As patient safety is our main priority, it is important to reiterate that there is no evidence that taking paracetamol during pregnancy causes autism in children,” states Chief Medical Officer, Dr. Nick Gent. “The use of medicines during pregnancy is rigorously assessed via bodies such as the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).  These assessments are based on the best available scientific evidence, as well as ongoing monitoring and surveillance of these medicines as they are used within the community.”

“Current studies have not shown a causal effect between paracetamol and Autism Spectrum Disorder. Patients should be reassured that paracetamol remains as the recommended first-choice pain reliever for pregnant women when used as directed.” explains Dr. Leroy Campbell, Consultant Obstetrician/Gynaecologist at the Health Services Authority (HSA).  “Fever and untreated severe pain in pregnancy carry real risks to both mother and baby, including miscarriage, preterm labor, and complications for the baby’s development. There are limited options available for the management of pain and fever in pregnancy, and paracetamol remains one of the drugs for which we have the most experience and historical data on its use during pregnancy. It is one of the safest options available, especially when compared to other pain-relief medications such as NSAIDs (ibuprofen, diclofenac and naproxen) or opioids which are not routinely recommended in pregnancy. Therefore, it is important for patients to manage these symptoms with the treatment recommended by their healthcare professionals, who will provide specific instructions on dosage, frequency and length of use.  Patients are reminded to always seek professional advice about any medicine taken in pregnancy and to follow the instructions given to them by their healthcare professionals.”

“Pregnancy is an incredibly vulnerable time for women due to the biological changes that our bodies go through, as well as psychological and social factors that can negatively impact health outcomes,” adds Chief Nursing Officer, Felicia McLean. “It is our responsibility, as healthcare professionals, to proactively address misinformation and ensure that our patients are empowered with both facts and ongoing support to make the best decision for themselves and their babies.”

Pregnant patients who have questions or need additional information should contact their healthcare professionals for additional information and guidance